MND

Sími: (+354) 565-5727

Radicava samþykkt sem lyf við MND. Fyrsta í 22 ár.

The U.S. Food and Drug Administration today approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis (MND/ALS), commonly referred to as Lou Gehrig’s disease.

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm557102.htm

Home Uncategorised Radicava samþykkt sem lyf við MND. Fyrsta í 22 ár.

Innskráning meðlima

Styrkja

Banki: 0516

Höfuðbók: 05

Reikningur: 410900

Kennitala: 630293-3089